RPN2 and glioblastoma: Accordingly, these results reveal that miR-181c inhibits glioma proliferation and enhances TMZ chemosensitivity, at least partially via RPN2, highlighting that miR-181c/RPN2/wnt axis may play significant roles in GBM progression and TMZ resistance.